Oxitocina Hikma (Oxytocin)

Oxytocin, the active ingredient in Oxitocina Hikma, is a peptide hormone presented as a sterile injectable solution for intramuscular use. It is employed to induce uterine contractions during labor and to control postpartum hemorrhage in obstetric patients. GNH USA supplies Oxitocina Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxitocina Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxitocina Hikma is a uterotonic peptide that acts on the uterine smooth muscle to promote contraction.

- Induction of labor: facilitates cervical dilation and progression of active labor. - Management of postpartum hemorrhage: supports uterine tone to reduce bleeding after delivery. - Induction of abortion: promotes uterine evacuation in early pregnancy termination procedures.

Oxytocin may cause a range of adverse reactions, most of which are dose‑dependent and related to its uterotonic activity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient headache during infusion. - Flushing: temporary facial redness. - Uterine hyperstimulation: excessive contractions. - Hypotension: drop in blood pressure, especially with rapid administration.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Myocardial ischemia: reduced blood flow to heart muscle. - Water intoxication: hyponatremia from excess fluid retention. - Severe allergic reaction: anaphylaxis or anaphylactoid response. - Uterine rupture: tearing of the uterine wall, particularly in a scarred uterus.

When using Oxitocina Hikma, clinicians should observe several safety measures to minimize risk.

- Monitor uterine activity: continuous fetal and uterine monitoring is essential. - Assess maternal cardiovascular status: watch for hypotension and tachycardia. - Avoid rapid bolus injection: administer slowly to reduce hyperstimulation. - Use caution in scarred uterus: increased risk of rupture. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Oxytocin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - General anesthetics: may potentiate uterine relaxation, reducing oxytocin effectiveness. - Magnesium sulfate: can diminish uterine contractility and increase risk of hyperstimulation.

Moderate Interactions (Monitor Closely): - Antihypertensives: may exacerbate hypotensive effects of oxyt4. - Beta‑adrenergic blockers. - Vasopressors. - Calcium channel blockers. - Diuretics. - Prostaglandin analogues. - NSAIDs. - Sedatives. - Opioid analgesics. - Anticholinergics. - Antidepressants. - Anticonvulsants. - Herbal supplements. - Vacc